Avenue Biosciences
A transatlantic biotechnology company specialising in novel protein engineering technologies
Helsinki, Finlandwww.avenuebiosciences.com ↗
Total raised
€7.2M
€7,203,024
Funding rounds
2
Investors
7
distinct backers
Active since
2024-10
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood31
base rate 44% for Seed
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 12% (2+ rounds)
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-12 | Seed | €4.9M | Balnord,Dimerent,Inventure,Tesi,University of Helsinki,Voima Ventures | View deal → |
| 2024-10-22 | Seed | €2.3M | Angel Investors,Inventure,Voima Ventures | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Nokia€859MFinland · Telecom